| Literature DB >> 28003592 |
Eddy Bagus Wasito1,2, Katsumi Shigemura3,4,5, Kayo Osawa4,5, Alpha Fardah6, Akiho Kanaida5, Dadik Raharjo4,2, K Kuntaman1,4, Usman Hadi7, Sugeng Harijono4,2, Subijanto Marto Sudarmo6, Tatsuya Nakamura8, Keigo Shibayama9, Masato Fujisawa3, Toshiro Shirakawa4,10.
Abstract
The purpose of this study was to investigate extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolates from pediatric (aged 0 to 3 years) diarrhea patients in Surabaya, Indonesia, where this kind of survey is rare; our study included assessment of their antibiotic susceptibilities, as well as ESBL typing, multilocus sequence typing (MLST), and diarrheagenic E. coli (DEC)-typing. ESBL-producing E. coli were detected in 18.8% of all the samples. Many ESBL-producing E. coli had significantly lower susceptibility to gentamicin (p < 0.0001) and the quinolones nalidixic acid (p=0.004) and ciprofloxacin (p < 0.0001) than non-producers. In ESBL-producing E. coli, 84.0% of strains expressed CTX-M-15 alone or in combination with other ESBL types. MLST revealed that 24.0% of ESBL-producers had sequence type 617, all of which expressed the CTX-M-15 gene; we also detected expression of 3 DEC-related genes: 2 enteroaggregative E. coli genes and 1 enteropathogenic E. coli gene. In conclusion, CTX-M-15-type ESBL-producing E. coli ST617 appear to have spread to Indonesia.Entities:
Keywords: CTX-M-15; ST617; diarrheagenic Escherichia coli; extended-spectrum beta-lactamase (ESBL)
Mesh:
Substances:
Year: 2016 PMID: 28003592 DOI: 10.7883/yoken.JJID.2016.234
Source DB: PubMed Journal: Jpn J Infect Dis ISSN: 1344-6304 Impact factor: 1.362